WuXi Biologics launches new manufacturing facility in China
Contract Manufacturing | News | 0 Comment | 26 Oct, 2022
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has successfully...Read more
Samsung Biologics unlocks additional capacity for production at newest Plant 4
Contract Manufacturing | News | 0 Comment | 12 Oct, 2022
Samsung Biologics, South Korea-based contract development and manufacturing organization (CDMO), has announced that its ...Read more
Fujifilm to establish first Bio-CDMO site in Japan
Contract Manufacturing | News | 0 Comment | 10 Oct, 2022
Fujifilm Corporation has announced that it will establish the company’s first Japanese Bio-CDMO (contract developm...Read more
Cytiva strengthens cell line development with CEVEC acquisition
Contract Manufacturing | News | 0 Comment | 06 Oct, 2022
Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cel...Read more
Samsung Biologics to launch new platforms for antibody development process
Contract Manufacturing | News | 0 Comment | 30 Sep, 2022
South Korea-based Samsung Biologics, a world-leading contract development and manufacturing organization (CDMO), is laun...Read more
Biosyngen boosts cell therapy GMP capabilities in Singapore
Contract Manufacturing | News | 0 Comment | 28 Sep, 2022
Singapore-based startup Biosyngen has signed to set up a cell therapy GMP facility which will serve as a base to develop...Read more
WuXi STA opens first high potency oral drug product manufacturing facility
Contract Manufacturing | News | 0 Comment | 28 Sep, 2022
WuXi STA, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the ope...Read more
Bora Pharma partners with TaiRx to manufacture breakthrough anticancer drug in Taiwan
Contract Manufacturing | News | 0 Comment | 26 Sep, 2022
Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals has partnered with TaiRx, Inc., a Tai...Read more
Hong Kong-based startup Great Bay Bio secures $15M funding
Contract Manufacturing | News | 0 Comment | 15 Sep, 2022
Great Bay Bio (GBB), Hong Kong-based startup, has announced the completion of its $15 million Pre-series B funding ...Read more
Catalent invests $2.2M for Singapore clinical supply facility expansion
Contract Manufacturing | News | 0 Comment | 07 Sep, 2022
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, lau...Read more
Dr Glenn Haifer and Ampersand Capital Partners acquire Australian biologics CDMO Luina Bio
Contract Manufacturing | News | 0 Comment | 01 Sep, 2022
AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr Gle...Read more
WuXi Biologics opens first North American biomanufacturing facility in New Jersey
Contract Manufacturing | News | 0 Comment | 01 Sep, 2022
China's WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has anno...Read more
WuXi announces licensing agreement with Janssen for TESSA technology
Contract Manufacturing | News | 0 Comment | 12 Aug, 2022
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of China-based WuXi AppTec, has announced a licensing agre...Read more
BioDuro-Sundia and X-Chem focus on new small molecule drug discovery in China
Contract Manufacturing | News | 0 Comment | 08 Aug, 2022
BioDuro-Sundia, an industry-leading drug discovery, development and commercial service contract research development and...Read more
How CDMOs are Adapting to New mRNA Tech Demands
Contract Manufacturing | Opinion | By Ayesha Siddiqui | 0 Comment | 30 Jul, 2022
The COVID-19 pandemic highlighted the successful development and utilisation of mRNA vaccines. This has encouraged bioph...Read more
WuXi Biologics invests $1.4 B to build comprehensive CRDMO centre in Singapore
Contract Manufacturing | News | 0 Comment | 19 Jul, 2022
WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has announced a ...Read more
Samsung Biologics further invests KRW 426 B for Bio Campus 2
Contract Manufacturing | News | 0 Comment | 18 Jul, 2022
Samsung Biologics, a South Korea-based contract development and manufacturing organization (CDMO), has signed a land pur...Read more
TFBS Biosciences expands state-of-the-art facility for viral vector production in Taiwan
Contract Manufacturing | News | 0 Comment | 15 Jul, 2022
TFBS Bioscience Inc., the leading GMP viral vector contract development and manufacturing organization in the Asia-Pacif...Read more